MSWM
TMO icon

Mader & Shannon Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Mader & Shannon Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.25M Buy
18,459
+259
+1% +$124K 4.32% 7
2026
Q1 		$8.95M Buy
18,200
+3,507
+24% +$1.9M 4.14% 7
2025
Q4 		$7.13M Hold
14,693
– – 3.49% 8
2025
Q3 		$7.13M Buy
14,693
+240
+2% +$112K 3.49% 8
2025
Q2 		$5.86M Buy
14,453
+72
+0.5% +$30.1K 3.19% 10
2025
Q1 		$7.16M Buy
14,381
+1,158
+9% +$627K 4.08% 8
2024
Q4 		$6.88M Sell
13,223
-58
-0.4% -$31.9K 4.25% 7
2024
Q3 		$8.22M Sell
13,281
-750
-5% -$444K 4.78% 8
2024
Q2 		$7.76M Sell
14,031
-672
-5% -$385K 4.66% 7
2024
Q1 		$8.55M Buy
14,703
+891
+6% +$500K 4.79% 6
2023
Q4 		$7.33M Buy
13,812
+201
+1% +$97.3K 4.17% 9
2023
Q3 		$6.89M Buy
13,611
+242
+2% +$129K 4.53% 8
2023
Q2 		$6.98M Buy
13,369
+600
+5% +$324K 4.31% 11
2023
Q1 		$7.36M Sell
12,769
-1,801
-12% -$1.02M 4.85% 10
2022
Q4 		$8.02M Buy
14,570
+3,355
+30% +$1.78M 5.31% 9
2022
Q3 		$5.69M Buy
11,215
+93
+0.8% +$52K 6.2% 6
2022
Q2 		$6.04M Sell
11,122
-2,651
-19% -$1.46M 3.61% 12
2022
Q1 		$8.13M Buy
13,773
+451
+3% +$259K 4.42% 7
2021
Q4 		$8.89M Buy
13,322
+190
+1% +$119K 4.92% 6
2021
Q3 		$7.5M Sell
13,132
-2
-0% -$1.1K 4.79% 6
2021
Q2 		$6.63M Buy
13,134
+3,418
+35% +$1.61M 3.41% 11
2021
Q1 		$4.43M Sell
9,716
-70
-0.7% -$33.4K 2.59% 19
2020
Q4 		$4.56M Buy
9,786
+618
+7% +$290K 3.02% 14
2020
Q3 		$4.05M Buy
9,168
+108
+1% +$44.6K 3.17% 9
2020
Q2 		$3.28M Buy
9,060
+279
+3% +$93.5K 2.67% 12
2020
Q1 		$2.49M Sell
8,781
-372
-4% -$117K 2.2% 11
2019
Q4 		$2.97M Buy
9,153
+282
+3% +$85.5K 2.39% 11
2019
Q3 		$2.58M Sell
8,871
-285
-3% -$81.6K 2.05% 12
2019
Q2 		$2.69M Buy
9,156
+5,802
+173% +$1.6M 2.29% 10
2019
Q1 		$918K Sell
3,354
-203
-6% -$50.5K 0.82% 11
2018
Q4 		$796K Buy
+3,557
New +$835K 0.65% 13

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mader & Shannon Wealth Management's TMO Position: Q2 2026 in Review

Mader & Shannon Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $124K and bringing the position to 18,459 shares worth $9.25M. The position accounts for 4.32% of the portfolio, ranked #7.

Mader & Shannon Wealth Management first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mader & Shannon Wealth Management held 18,459 shares of Thermo Fisher Scientific worth $9.25M as of Q2 2026.
  • Mader & Shannon Wealth Management bought 259 Thermo Fisher Scientific shares in Q2 2026, an estimated $124K.
  • Thermo Fisher Scientific made up 4.32% of Mader & Shannon Wealth Management's portfolio in Q2 2026, its #7 holding.
  • Mader & Shannon Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mader & Shannon Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.